Digital Healthcare Stocks Poised for a Breakout: Oscar and Hims & Hers Health Leading the Way

Two digital healthcare stocks, Oscar Health and Hims & Hers Health, are poised for a breakout despite recent challenges. Oscar Health reported a 42% YoY revenue increase to $3 billion and a 55% profit growth, while Hims & Hers Health saw a 111% YoY revenue surge to $586 million. However, Oscar Health faces cost pressure and volatility, and Hims & Hers Health is navigating regulatory scrutiny and partnership disputes. Both companies have scalable technology models and massive total addressable markets, making them potential long-term investment opportunities.

Two digital healthcare stocks, Oscar Health, Inc. (OSCR) and Hims & Hers Health, Inc. (HIMS), are poised for a breakout despite recent challenges. Oscar Health reported a 42% year-over-year (YoY) revenue increase to $3 billion and a 55% profit growth, while Hims & Hers Health saw an 111% YoY revenue surge to $586 million [1].

However, Oscar Health faces cost pressure and volatility. The company closed at $14.20 in the latest trading session, marking a -10.52% move from the prior day [1]. Despite this, Oscar Health is expected to report an earnings per share (EPS) of -$0.51, showcasing a 355% downward movement from the corresponding quarter of the prior year. The company's Zacks Rank is currently at #4 (Sell), indicating a cautious outlook [1].

On the other hand, Hims & Hers Health has been trading up by 15.56% following positive sentiment from noteworthy strategic partnerships. The company's stock has gained 1.6% in the latest trading session, setting the market abuzz with expectations of more positive outcomes [2]. The company is set to expand to Canada by 2026, introducing generic semaglutide, a key ingredient in weight-loss treatments. However, the company is navigating regulatory scrutiny and partnership disputes, which could pose hurdles to its growth [2].

Both companies have scalable technology models and massive total addressable markets, making them potential long-term investment opportunities. Despite their challenges, investors should keep a close eye on these companies as they continue to innovate and expand in the digital healthcare space.

References:
[1] https://www.nasdaq.com/articles/oscar-health-inc-oscr-stock-declines-while-market-improves-some-information-investors-0
[2] https://stockstotrade.com/news/hims-hers-health-inc-hims-news-2025_07_23/